产品说明书

Furazolidone

Print
Chemical Structure| 67-45-8 同义名 : Furoxone;Trifurox;Furazolidon;Furazolidine;Tikofuran;Nitrofuroxon;Nitrofurazolidone;Nifulidone;NSC 6469
CAS号 : 67-45-8
货号 : A515238
分子式 : C8H7N3O5
纯度 : 99%
分子量 : 225.158
MDL号 : MFCD00010550
存储条件:

粉末 Keep in dark place,Sealed in dry,Room Temperature

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 4 mg/mL(17.77 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 Furazolidone (FZD) is a nitrofuran derivative with antiprotozoal and antibacterial activity, inhibits AML1-ETO (Acute myeloid leukemia ) transformed cells with IC50 value of 12.7 μM[3]. Biological in vitro evaluations demonstrated that free FZD and the FZD:β-CD complexes presented significant leishmanicidal activity against L. amazonensis with IC50 values of 6.16 μg/mL and 1.83 μg/mL for the complexes prepared by kneading and lyophilization, respectively[4]. Moreover, furazolidone was more effective and better tolerated than quinacrine for the treatment of giardiasis[5]. Furazolidone is known to induce a condition of cardiomyopathy in turkeys, which could be used as a model to study alpha 1-antitrypsin deficiency in man[6].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT03320538 Peptic Ulcer Disease Not Applicable Recruiting July 1, 2019 China, Jiangxi ... 展开 >> Jiangxi University of Traditional Chinese Medicine Recruiting Nanchang, Jiangxi, China, 330004 Contact: Xu Zhou, Ph.D.    +8618780085060    zhouxu_ebm@hotmail.com    Contact: Xiaofan Chen, Ph.D.    +86079187118012    841347982@qq.com 收起 <<
NCT02689583 Gastritis Gas... 展开 >>tric Ulcer 收起 << Not Applicable Unknown - -
NCT02934048 Therapeutic Duration ... 展开 >> Helicobacter Pylori Antimicrobial Susceptibility Test Eradication 收起 << Phase 4 Unknown June 2017 -
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

4.44mL

0.89mL

0.44mL

22.21mL

4.44mL

2.22mL

44.41mL

8.88mL

4.44mL

参考文献

[1]Jiang X, Sun L, et al. A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia. PLoS One. 2013 Aug 9;8(8):e72335. doi: 10.1371/journal.pone.0072335. eCollection 2013.

[2]Alam MI, Paget T, et al. Formulation and advantages of furazolidone in liposomal drug delivery systems. Eur J Pharm Sci. 2016 Mar 10;84:139-45.

[3]Jiang X, Sun L, Qiu JJ, et al. A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia. PLoS One. 2013;8(8):e72335. Published 2013 Aug 9.

[4]Carvalho SG, Siqueira LA, Zanini MS, et al. Physicochemical and in vitro biological evaluations of furazolidone-based β-cyclodextrin complexes in Leishmania amazonensis. Res Vet Sci. 2018;119:143–153.

[5]Craft JC, Murphy T, Nelson JD. Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children. Am J Dis Child. 1981;135(2):164–166.

[6]Ali BH. Some pharmacological and toxicological properties of furazolidone. Vet Res Commun. 1983;6(1):1–11.